Xu Jianjiang, Liu Zuguo, Mashaghi Alireza, Sun Xinghuai, Lu Yi, Li Yimin, Wu Dan, Yang Yujing, Wei Anji, Zhao Yujin, Lu Chun, Hong Jiaxu
From the Department of Ophthalmology and Visual Science, Eye, and ENT Hospital, Shanghai Medical College, Fudan University, Shanghai (JX, XS, YL, YL, DW, YY, AW, YZ, CL, JH); School of Life Sciences, Xiamen University, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian, China (ZL, JH); Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA (AM, JH); and China State Key Laboratory of Medical Neurobiology, Institutes of Brain Science (XS); Key Laboratory of Myopia, National Health and Family Planning Commission, Shanghai, China (XS).
Medicine (Baltimore). 2015 Sep;94(39):e1611. doi: 10.1097/MD.0000000000001611.
In patients with primary canaliculitis, conservative medical therapy is associated with a high recurrence rate. Surgical treatments carry a great resolution rate but sometimes can result in the lacrimal pump dysfunction and canalicular scarring. The aim of this study is to introduce a minimally invasive approach, intracanalicular ophthalmic corticosteroid/antibiotic combination ointment infiltration (IOI, intracanalicular ointment infiltration), and to report our preliminary results for treating primary canaliculitis. In this retrospective, interventional case series, 68 consecutive patients with newly developed primary canaliculitis at a major tertiary eye center between January 2012 and January 2015. Thirty-six patients received conservative medical treatment alone (group 1; 36 eyes). Twenty-two patients and 10 medically uncontrolled patients from group 1 underwent IOI therapy (group 2; 32 eyes). Ten patients and 26 recurrent patients from group 1 and group 2 underwent surgery (group 3; 36 eyes). Patients were followed-up for at least 8 weeks. Clinical characteristics and outcomes were analyzed and compared. In this study, patients' age, sex, onset location, and durations of disease among 3 groups showed no significant difference. The resolution rate in group 2 was 72.7% (16/22) for new patients and 68.8% (22/32) for gross patients, respectively, both of which are higher than that of group 1 (22.2%, 10/36) but lower than that of group 3 (100%, 36/36). Of group 3, 2 patients received 2 surgical interventions and resolved finally. Microbiological workup was available in 51 patients. The most common isolates were staphylococcus species (27.9%) and streptococcus species (20%). Canalicular laceration developed in 1 patient during the IOI procedure and 1 patient undergoing surgery. Only 2 had postoperative lacrimal pump dysfunction and 1 had canalicular scarring in group 3. The IOI may be an effective and minimally invasive technique for treating primary canaliculitis and obviate the need for further intensive surgery.
在原发性泪小管炎患者中,保守药物治疗的复发率较高。手术治疗的治愈率很高,但有时会导致泪泵功能障碍和泪小管瘢痕形成。本研究的目的是介绍一种微创方法,即泪小管内眼用皮质类固醇/抗生素联合软膏浸润(IOI,泪小管内软膏浸润),并报告我们治疗原发性泪小管炎的初步结果。在这个回顾性的介入性病例系列中,连续纳入了2012年1月至2015年1月期间在一家大型三级眼科中心新诊断为原发性泪小管炎的68例患者。36例患者仅接受保守药物治疗(第1组;36只眼)。第1组中的22例患者和10例药物治疗无效的患者接受了IOI治疗(第2组;32只眼)。第1组和第2组中的10例患者以及26例复发患者接受了手术(第3组;36只眼)。对患者进行了至少8周的随访。分析并比较了临床特征和治疗结果。在本研究中,3组患者的年龄、性别、发病部位和病程无显著差异。第2组新患者的治愈率为72.7%(16/22),总患者的治愈率为68.8%(22/32),均高于第1组(22.2%,10/36),但低于第3组(100%,36/36)。在第3组中,2例患者接受了2次手术干预,最终治愈。51例患者进行了微生物学检查。最常见的分离菌是葡萄球菌属(27.9%)和链球菌属(20%)。在IOI操作过程中有1例患者发生泪小管撕裂,1例手术患者发生泪小管撕裂。第3组中只有2例有术后泪泵功能障碍,1例有泪小管瘢痕形成。IOI可能是一种治疗原发性泪小管炎的有效且微创的技术,可避免进一步进行复杂手术的需要。